DK0623123T3 - Benzopyran og beslægtede LTB4-antagonister - Google Patents

Benzopyran og beslægtede LTB4-antagonister

Info

Publication number: DK0623123T3
Authority: DK; Denmark
Prior art keywords: benzopyran; ltb4 antagonists; related ltb4; antagonists; ltb4
Prior art date: 1992-01-23

Application number

DK92924284.0T

Other languages

Danish (da)

English (en)

Inventor

Kevin Koch

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-23

Filing date

1992-11-13

Publication date

1997-10-13

1992-11-13 Application filed by Pfizer filed Critical Pfizer

1997-10-13 Application granted granted Critical

1997-10-13 Publication of DK0623123T3 publication Critical patent/DK0623123T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK92924284.0T 1992-01-23 1992-11-13 Benzopyran og beslægtede LTB4-antagonister DK0623123T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US82441292A	1992-01-23	1992-01-23

Publications (1)

Publication Number	Publication Date
DK0623123T3 true DK0623123T3 (da)	1997-10-13

Family

ID=25241346

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92924284.0T DK0623123T3 (da)	1992-01-23	1992-11-13	Benzopyran og beslægtede LTB4-antagonister

Country Status (36)

Country	Link
US (2)	US5552435A (fr)
EP (1)	EP0623123B1 (fr)
JP (1)	JP2765757B2 (fr)
KR (2)	KR0124802B1 (fr)
CN (1)	CN1041311C (fr)
AP (1)	AP352A (fr)
AT (1)	ATE152108T1 (fr)
AU (1)	AU666896B2 (fr)
BG (1)	BG62331B1 (fr)
BR (1)	BR9207061A (fr)
CA (1)	CA2126752C (fr)
CZ (1)	CZ282400B6 (fr)
DE (1)	DE69219364T2 (fr)
DK (1)	DK0623123T3 (fr)
EG (1)	EG20202A (fr)
FI (1)	FI943474A0 (fr)
GR (1)	GR3023657T3 (fr)
HU (1)	HU221194B1 (fr)
IL (1)	IL104386A (fr)
IS (1)	IS1795B (fr)
MX (1)	MX9300312A (fr)
MY (1)	MY109144A (fr)
NO (1)	NO306508B1 (fr)
NZ (1)	NZ245735A (fr)
OA (1)	OA11456A (fr)
PH (1)	PH30346A (fr)
PL (1)	PL171003B1 (fr)
PT (1)	PT101183B (fr)
RO (1)	RO112031B1 (fr)
RU (1)	RU2114110C1 (fr)
SG (1)	SG49813A1 (fr)
SK (1)	SK280451B6 (fr)
TW (1)	TW213907B (fr)
WO (1)	WO1993015067A1 (fr)
YU (1)	YU48949B (fr)
ZA (1)	ZA93486B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2084547B1 (es) *	1993-07-12	1997-01-16	Pfizer	Antagonistas benzopiranicos y relacionados de leucotrieno b4.
NZ285154A (en) *	1994-10-13	1998-11-25	Pfizer	Optionally heterocyclically substituted benzopyran and benzo-fused derivatives, preparation and use as leukotriene antagonists
CN1160399A (zh) *	1994-10-13	1997-09-24	美国辉瑞有限公司	苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途
AU713701B2 (en) *	1996-09-16	1999-12-09	Pfizer Inc.	Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en)	1996-10-07	2002-07-09	Bristol-Myers Squibb Pharma Company	Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (fr) *	1996-10-17	2000-11-29	Pfizer Inc.	Méthode pour prévenir le rejet d'allogreffes
EP0963755A3 (fr) *	1998-04-16	2001-03-14	Pfizer Products Inc.	Utilisation des benzopyranes pour la prévention de rejets de graiffes
US6436987B1 (en) *	2000-06-08	2002-08-20	Pfizer Inc.	Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
US6770259B2 (en)	2000-11-03	2004-08-03	Bristol-Myers Squibb Pharma Company	Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
CA2433516A1 (fr) *	2001-01-30	2002-08-08	Keith Michael Devries	Procedes de preparation d'acides chromanylbenzoiques
AU4239302A (en) *	2001-06-28	2003-01-02	Pfizer Products Inc.	Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
JP2008506768A (ja) *	2004-07-22	2008-03-06	ファルマシアコーポレーション	Ｃｏｘ−２選択的阻害剤とｌｔｂ４受容体アンタゴニストを組み合わせて用いる炎症および疼痛を治療するための組成物
WO2017095724A1 (fr)	2015-11-30	2017-06-08	Merck Sharp & Dohme Corp.	Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
US10336733B2 (en)	2015-11-30	2019-07-02	Merk Sharp & Dohme Corp.	Aryl acylsulfonamides as BLT1 antagonists
US10370368B2 (en)	2015-11-30	2019-08-06	Merck Sharp & Dohme Corp.	Aryl acylsulfonamides as BLT1 antagonists
EP3383869B1 (fr)	2015-11-30	2023-06-28	Merck Sharp & Dohme LLC	Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2309282A1 (de) *	1973-02-24	1974-08-29	Hoechst Ag	Verfahren zur herstellung von 4-hydroxy-thiochromanen
DE2745305A1 (de) *	1977-10-07	1979-04-19	Bayer Ag	Insektizide und akarizide mittel
US4565882A (en) *	1984-01-06	1986-01-21	G. D. Searle & Co.	Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (fr) *	1987-01-12	1993-07-20	Darrel M. Gapinski	Agents antiinflammatoires
JPS63292977A (ja) *	1987-05-25	1988-11-30	片山　晋	スキ−用のビンディング固定板
US5059609A (en) *	1987-10-19	1991-10-22	Pfizer Inc.	Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
MX13485A (es) *	1987-10-19	1993-05-01	Pfizer	Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
WO1990012010A1 (fr) *	1989-04-07	1990-10-18	Pfizer Inc.	Chromans substitues pour le traitement de l'asthme, de l'arthrite et de maladies apparentees
WO1990015801A1 (fr) *	1989-06-22	1990-12-27	Pfizer Inc.	Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees
FI923546L (fi) *	1990-02-07	1992-08-06	Pfizer	Tetralin- och kromanderivat anvaendbara vid vaord av astma, ledinflammation och motsvarande sjukdomar.
ES2098547T3 (es) *	1992-01-23	1997-05-01	Pfizer	Benzopirano y otros antagonistas de ltb4 relacionados.
EP0558245A1 (fr) *	1992-02-25	1993-09-01	RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY	Composés hétérobicycliques comme antagonistes des récepteurs alpha-1 adrénergiques et 5HT1A
FR2693196B1 (fr) *	1992-07-03	1994-12-23	Lipha	Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.

1992
- 1992-01-22 MX MX9300312A patent/MX9300312A/es not_active IP Right Cessation
- 1992-11-13 BR BR9207061A patent/BR9207061A/pt not_active Application Discontinuation
- 1992-11-13 KR KR1019940702518A patent/KR0124802B1/ko not_active Expired - Fee Related
- 1992-11-13 PL PL92304689A patent/PL171003B1/pl unknown
- 1992-11-13 DK DK92924284.0T patent/DK0623123T3/da active
- 1992-11-13 HU HU9401979A patent/HU221194B1/hu not_active IP Right Cessation
- 1992-11-13 US US08/295,827 patent/US5552435A/en not_active Expired - Lifetime
- 1992-11-13 RO RO94-01220A patent/RO112031B1/ro unknown
- 1992-11-13 DE DE69219364T patent/DE69219364T2/de not_active Expired - Lifetime
- 1992-11-13 AT AT92924284T patent/ATE152108T1/de not_active IP Right Cessation
- 1992-11-13 RU RU94035964/04A patent/RU2114110C1/ru not_active IP Right Cessation
- 1992-11-13 JP JP5513184A patent/JP2765757B2/ja not_active Expired - Lifetime
- 1992-11-13 SG SG1996006699A patent/SG49813A1/en unknown
- 1992-11-13 SK SK844-94A patent/SK280451B6/sk unknown
- 1992-11-13 AU AU30650/92A patent/AU666896B2/en not_active Ceased
- 1992-11-13 WO PCT/US1992/009496 patent/WO1993015067A1/fr not_active Ceased
- 1992-11-13 EP EP92924284A patent/EP0623123B1/fr not_active Expired - Lifetime
- 1992-11-13 FI FI943474A patent/FI943474A0/fi not_active IP Right Cessation
- 1992-11-13 CA CA002126752A patent/CA2126752C/fr not_active Expired - Lifetime
- 1992-11-13 CZ CZ941762A patent/CZ282400B6/cs not_active IP Right Cessation
- 1992-11-17 TW TW081109200A patent/TW213907B/zh active
- 1992-11-20 AP APAP/P/1992/000449A patent/AP352A/en active
1993
- 1993-01-02 EG EG3293A patent/EG20202A/xx active
- 1993-01-13 PH PH45558D patent/PH30346A/en unknown
- 1993-01-14 IL IL10438693A patent/IL104386A/en not_active IP Right Cessation
- 1993-01-19 IS IS3969A patent/IS1795B/is unknown
- 1993-01-19 MY MYPI93000086A patent/MY109144A/en unknown
- 1993-01-21 CN CN93100769A patent/CN1041311C/zh not_active Expired - Fee Related
- 1993-01-22 YU YU3393A patent/YU48949B/sh unknown
- 1993-01-22 PT PT101183A patent/PT101183B/pt not_active IP Right Cessation
- 1993-01-22 ZA ZA93486A patent/ZA93486B/xx unknown
- 1993-01-22 NZ NZ245735A patent/NZ245735A/en unknown
1994
- 1994-06-21 BG BG98867A patent/BG62331B1/bg unknown
- 1994-07-22 NO NO942759A patent/NO306508B1/no not_active IP Right Cessation
- 1994-07-22 OA OA60543A patent/OA11456A/en unknown
- 1994-07-22 KR KR1019940702518A patent/KR950700273A/ko active Granted
1996
- 1996-05-03 US US08/642,711 patent/US5684046A/en not_active Expired - Lifetime
1997
- 1997-06-04 GR GR970401301T patent/GR3023657T3/el unknown

Also Published As

Publication number	Publication date
BR9207061A (pt)	1995-12-26
RU2114110C1 (ru)	1998-06-27
IL104386A0 (en)	1993-05-13
PL171003B1 (pl)	1997-02-28
BG98867A (bg)	1995-03-31
OA11456A (en)	2003-11-18
JPH07502536A (ja)	1995-03-16
PH30346A (en)	1997-04-02
EP0623123B1 (fr)	1997-04-23
HU9401979D0 (en)	1994-09-28
HK1000245A1 (en)	1998-02-13
IL104386A (en)	2001-05-20
DE69219364D1 (de)	1997-05-28
IS3969A (is)	1993-07-24
AU666896B2 (en)	1996-02-29
FI943474L (fi)	1994-07-22
US5684046A (en)	1997-11-04
ZA93486B (en)	1994-07-22
CA2126752C (fr)	2000-05-16
AP352A (en)	1994-08-10
CZ176294A3 (en)	1995-02-15
PT101183A (pt)	1994-03-31
GR3023657T3 (en)	1997-09-30
AP9200449A0 (en)	1993-01-31
HUT68790A (en)	1995-07-28
BG62331B1 (bg)	1999-08-31
AU3065092A (en)	1993-09-01
NZ245735A (en)	1995-04-27
PT101183B (pt)	1999-09-30
MY109144A (en)	1996-12-31
SG49813A1 (en)	1998-06-15
SK280451B6 (sk)	2000-02-14
TW213907B (fr)	1993-10-01
MX9300312A (es)	1993-07-31
RU94035964A (ru)	1997-05-27
YU3393A (sh)	1996-07-24
JP2765757B2 (ja)	1998-06-18
IS1795B (is)	2001-12-18
CA2126752A1 (fr)	1993-08-05
KR0124802B1 (ko)	1997-11-25
NO942759L (no)	1994-07-22
YU48949B (sh)	2003-01-31
EP0623123A1 (fr)	1994-11-09
DE69219364T2 (de)	1997-08-07
FI943474A7 (fi)	1994-07-22
FI943474A0 (fi)	1994-07-22
CN1041311C (zh)	1998-12-23
NO306508B1 (no)	1999-11-15
HU221194B1 (en)	2002-08-28
RO112031B1 (ro)	1997-04-30
CZ282400B6 (cs)	1997-07-16
WO1993015067A1 (fr)	1993-08-05
ATE152108T1 (de)	1997-05-15
SK84494A3 (en)	1995-05-10
CN1075318A (zh)	1993-08-18
US5552435A (en)	1996-09-03
EG20202A (en)	1997-10-30
NO942759D0 (no)	1994-07-22
KR950700273A (ko)	1995-01-16

Publication	Publication Date	Title
DK0623122T3 (da)	1997-04-21	Benzopyran og beslægtede LTB4-antagonister
NO961425D0 (no)	1996-04-11	1N-alkyl-N-arylpyrimidinaminer og derivater derav
DE59208263D1 (de)	1997-04-30	3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
NO943763D0 (no)	1994-10-06	4-arylamino-benzopyraner og beslektede forbindelser
PT551048E (pt)	2002-12-31	Derivados de 2-imidazolina-5-ona e 2-imidazolina-5-tionas fungicidas
DK0623123T3 (da)	1997-10-13	Benzopyran og beslægtede LTB4-antagonister
FI933201L (fi)	1994-01-17	Vaerme- och kylvals
NO922934D0 (no)	1992-07-23	Cykloheksan- og tetrahydropyranderivater
FI933019L (fi)	1994-01-02	Bensotiazepin- och bensoxatzepinderivat
BR9205281A (pt)	1993-07-27	Pentapeptideos imuno-reguladores e neuro-reguladores
FI1031U1 (fi)	1993-11-19	En troakar
ITMI921571A1 (it)	1993-12-26	Azaciclo e azabiciclo alchiliden idrossilamine
LV10955A (lv)	1995-12-20	Benzopirana atvasinajumi
DK619589A (da)	1990-06-10	Sphingenin og derivater heraf
DK94288D0 (da)	1988-02-23	Stillads og stilladsbuk dertil
FI901088A7 (fi)	1990-09-04	Aminoetyylitiatsoli- ja aminoetyylioksatsolijohdannaisia